| Completed | Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma Progress Free Survival (PFS) and Overall Survival (OS) | Phase 2 | 2020-05-11 |
| Completed | Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC Locally Advanced Pancreatic Adenocarcinoma | Phase 2 / Phase 3 | 2019-09-01 |
| Withdrawn | Very Small Embryonic-like Stem Cells for Facial Skin Antiaging Stem Cell Transplant Complications, Skin Inflammation | Phase 1 / Phase 2 | 2019-07-06 |
| Withdrawn | Very Small Embryonic-like Stem Cells for Knee Osteoarthritis Stem Cell Transplant Complications, Knee Osteoarthritis | Phase 1 / Phase 2 | 2019-07-05 |
| Withdrawn | Very Small Embryonic-like Stem Cells for Ovary Stem Cell Transplant Complications, Premature Ovarian Failure | Phase 1 / Phase 2 | 2019-07-03 |
| Withdrawn | Very Small Embryonic-like Stem Cells for Erectile Dysfunction Organic Erectile Dysfunction | Phase 1 / Phase 2 | 2019-07-01 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer Advanced Breast Cancer | Phase 2 | 2019-05-20 |
| Completed | Hydrogen Gas for Cancer Rehabilitation Adult Solid Tumor | N/A | 2018-06-02 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 2 | 2018-04-12 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer Advanced Kidney Cancer | Phase 2 | 2018-04-10 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer Advanced Gastric Cancer | Phase 2 | 2018-04-05 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer Advanced Colorectal Cancer | Phase 2 | 2018-04-05 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer Advanced Lung Cancer | Phase 2 | 2018-03-27 |
| Withdrawn | Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer Advanced Liver Cancer | Phase 2 | 2018-03-25 |
| Completed | Mix Vaccine for Metastatic Kidney Cancer Metastasis From Malignant Tumor of Kidney (Disorder), Reaction - Mixed Vaccine | Phase 1 / Phase 2 | 2017-11-30 |
| Completed | Mix Vaccine for Metastatic Colorectal Cancer Metastatic Colorectal Cancer, Reaction - Mixed Vaccine | Phase 1 / Phase 2 | 2017-11-30 |
| Completed | Bioinformation Therapy for Gastric Cancer Advanced Gastric Cancer | Phase 2 / Phase 3 | 2017-11-30 |
| Completed | Bioinformation Therapy for Intestinal Cancer Advanced Intestinal Cancer | Phase 2 / Phase 3 | 2017-11-30 |
| Completed | Mix Vaccine for Metastatic Sarcoma Patients Metastatic Sarcoma, Reaction - Mixed Vaccine | Phase 1 / Phase 2 | 2017-11-30 |
| Completed | PENS or TENS for Pain in Liver Cancer Pain, Cancer Pain, Liver Neoplasms | N/A | 2017-11-01 |
| Completed | PENS or TENS for Pain in Pancreatic Cancer Pain, Cancer Pain, Pancreatic Cancer | N/A | 2017-10-27 |
| Completed | Bioinformation Therapy for Lung Cancer Small-cell Lung Cancer | Phase 2 / Phase 3 | 2017-09-02 |
| Completed | Bioinformation Therapy for Liver Cancer Liver, Cancer of, Non-Resectable | Phase 2 / Phase 3 | 2017-09-02 |
| Completed | Bioinformation Therapy for Breast Cancer Advanced Breast Cancer | Phase 2 / Phase 3 | 2017-09-02 |
| Completed | Bioinformation Therapy for Pancreatic Cancer Unresectable Pancreatic Cancer | Phase 2 / Phase 3 | 2017-09-01 |
| Completed | Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2017-06-15 |
| Completed | Safety and Efficiency of γδ T Cell Against Lung Cancer Lung Cancer | Phase 1 / Phase 2 | 2017-06-15 |
| Completed | Safety and Efficiency of γδ T Cell Against Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2017-06-15 |
| Completed | Safety and Efficiency of γδ T Cell Against Liver Cancer Liver Cancer | Phase 1 / Phase 2 | 2017-06-15 |
| Completed | Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation) Lung Cancer | Phase 1 / Phase 2 | 2017-06-08 |
| Completed | High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma Melanoma | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer Metastatic Nasopharyngeal Cancer | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer Non-small Cell Lung Cancer Metastatic | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer Recurrent Liver Carcinoma | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer Tongue Cancer | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer Pancreatic Cancer | N/A | 2016-10-01 |
| Completed | Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors Malignant Solid Tumour | Phase 1 / Phase 2 | 2016-08-01 |
| Completed | Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer Recurrent Cervical Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Rituximab and NK Immunotherapy for B Lymphoma B-cell Lymphoma Recurrent | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer Non-small Cell Lung Cancer Metastatic | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer Recurrent Breast Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer Recurrent Pharyngeal Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer Recurrent Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors Malignant Solid Tumour | Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer Breast Cancer Recurrent | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer Recurrent Ovarian Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors Malignant Solid Tumour | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver Liver Tumor, Evidence of Liver Transplantation | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma Recurrent Adult Soft Tissue Sarcoma | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer Secondary Malignant Neoplasm of Liver | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer Metastatic Renal Cell Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer Metastatic Esophageal Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer Recurrent Tongue Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer Recurrent Laryngeal Cancer | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | Cryotherapy Combine Icotinib for Advanced NSCLC Treatment Lung Neoplasms | Phase 4 | 2016-04-01 |
| Completed | Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2016-03-01 |
| Withdrawn | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients GD2 Positive Glioma, CAR-T Cell Immunotherapy | Phase 1 / Phase 2 | 2015-10-15 |
| Withdrawn | CD19-targeting CAR T Cells for B Cell Lymphoma B Cell Lymphoma | Phase 1 / Phase 2 | 2015-09-01 |
| Withdrawn | Chimeric Antigen Receptor-Modified T Cells for Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2015-09-01 |
| Withdrawn | CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients EphA2 Positive Malignant Glioma, CAR-T Cell Immunotherapy | Phase 1 / Phase 2 | 2015-09-01 |
| Withdrawn | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients Glioma of Brain, CAR-T Cell Immunotherapy | Phase 1 / Phase 2 | 2015-09-01 |
| Completed | Liver Cancer HepaSphere Combined With Cryosurgery Liver Cancer | Phase 1 / Phase 2 | 2015-08-01 |
| Withdrawn | CAR-T Cell Immunotherapy for HCC Targeting GPC3 GPC3 Positive Hepatocellular Carcinoma, CAR-T Cell Immunotherapy | Phase 1 / Phase 2 | 2015-06-01 |
| Completed | Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma Liver Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer Lung Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer Liver Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma Cervical Carcinoma | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | 2015-05-01 |
| Withdrawn | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma Lung Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Completed | Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) Breast Cancer | Phase 1 / Phase 2 | 2015-04-01 |
| Completed | Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer Liver Cancer | Phase 1 / Phase 2 | 2015-04-01 |
| Completed | Percutaneous Irreversible Electroportion for Unresectable Breast Cancer Breast Cancer | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms Head and Neck Neoplasms | N/A | 2015-01-01 |
| Completed | Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient Prostatic Neoplasms | Phase 1 / Phase 2 | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms Rectal Neoplasms | N/A | 2015-01-01 |
| Completed | Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder Hepatic Carcinoma | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms Uterine Cervical Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms Esophageal Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli Liver Cancer | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms Renal Pelvic and Ureteral Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency Lung Neoplasms Accompanied by Respiratory Function Insufficiency | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms Gallbladder Neoplasms | N/A | 2015-01-01 |
| Withdrawn | Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms Prostatic Neoplasms | N/A | 2015-01-01 |
| Completed | Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient Pancreatic Neoplasms | Phase 1 / Phase 2 | 2015-01-01 |
| Completed | Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient Breast Neoplasms | Phase 1 / Phase 2 | 2015-01-01 |
| Completed | Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function Hepatic Carcinoma | N/A | 2015-01-01 |
| Completed | Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient Lung Neoplasms | Phase 1 / Phase 2 | 2015-01-01 |
| Completed | Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer Pancreatic Cancer | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms Urinary Bladder Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms Hilus Pulmonary Neoplasms | N/A | 2015-01-01 |
| Completed | Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient Liver Neoplasms | Phase 1 / Phase 2 | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve) Lymph Node Metastases | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms Stomach Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms Laryngeal Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms Extremities Neoplasms | N/A | 2015-01-01 |
| Completed | Irreversible Electroporation(IRE) For Unresectable Renal Tumors Renal Tumor | N/A | 2015-01-01 |
| Completed | Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome Liver Cancer | N/A | 2014-12-01 |
| Completed | A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer Neoplasms,Colorectal | Phase 1 / Phase 2 | 2014-06-01 |
| Completed | Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine Neoplasms,Ovarian | Phase 1 / Phase 2 | 2014-06-01 |
| Completed | The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine Neoplasms, Lung | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells Neoplasms, Lung | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer Neoplasms, Pancreas | Phase 1 / Phase 2 | 2014-02-01 |
| Completed | Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients Neoplasms, Liver | Phase 1 / Phase 2 | 2014-02-01 |
| Completed | Safety Study of Cancer Stem Cell Vaccinie to Treat Breast Cancer Neoplasms, Breast | — | 2014-01-01 |
| Completed | The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined Neoplastic Cells, Circulating | — | 2013-06-01 |
| Completed | The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment Neoplastic Cells, Circulating | — | 2013-06-01 |
| Completed | The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Comb Neoplastic Cells, Circulating | — | 2013-06-01 |
| Completed | The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined Neoplastic Cells, Circulating | — | 2013-06-01 |
| Completed | The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined W Neoplastic Cells, Circulating | — | 2013-06-01 |
| Completed | The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined Neoplastic Cells, Circulating | — | 2013-06-01 |
| Completed | The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combi Neoplastic Cells, Circulating | — | 2013-06-01 |
| No Longer Available | Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma Pancreatic Cancer | — | — |